Evan L. Wasoff - 23 May 2024 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Signature
Evan L. Wasoff
Issuer symbol
NXEN
Transactions as of
23 May 2024
Transactions value $
$0
Form type
4
Filing time
28 May 2024, 11:57:51 UTC
Previous filing
02 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common stock Award +2,000,000 +44.4% 6,500,000 23 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Options to purchase common stock (right to buy) 1,500,000 23 May 2024 common stock 1,500,000 $0.0800 Direct
holding NXEN Options to purchase common stock (right to buy) 420,000 23 May 2024 common stock 420,000 $0.5400 Direct
holding NXEN Options to purchase common stock (right to buy) 200,000 23 May 2024 common stock 200,000 $0.6550 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.